Getting to the Heart of the Matter: Medscape Education at AHA 2024!
November 12, 2024 | AHA24, CME, Cardiovascular, Symposia, cardiology, cardiomyopathy, hypertension
Come join Medscape Education at the American Heart Association (AHA) 2024 Scientific Sessions in Chicago, IL, from November 16-18 — a dynamic event packed with cutting-edge cardiology education that you won’t want to miss! 🚀 This year, we are hosting 6 highly interactive symposia, each designed to elevate the learner’s expertise and knowledge, while diving deep into the latest advancements in Cardiology!
Key Symposia at AHA 2024
Our carefully curated symposia cover a broad range of critical cardiology topics, ensuring that attendees are well-equipped to tackle emerging challenges in cardiovascular health. Here’s a preview of what you can expect:
Saturday, November 16
1. Proactive Cardiovascular Protection Along the Cardiac Continuum: Understanding Risk to Optimize Prevention: Explore cutting-edge strategies in proactive cardiovascular protection. By understanding the full spectrum of cardiovascular risk, we can improve prevention efforts and outcomes.
2. Navigating New Paradigms in Thrombosis Management: Gameshow Evaluation of Evolving Anticoagulation Approaches: This interactive “gameshow” format, is designed to engage learners in the latest advancements in anticoagulation therapies and their role in thrombosis management.
Sunday, November 17
3. From Challenge to Control: Innovative Therapies in Hypertension Management: Discover the recent innovations in the treatment of hypertension, including novel therapies and management strategies aimed at overcoming the challenges faced by clinicians.
4. Transforming Perspectives on Transthyretin Amyloid Cardiomyopathy: Insights Into Evolving Advances: Learn about recent advances in diagnostics and treatment options for Transthyretin amyloid cardiomyopathy.
5. Heart Failure with Preserved or Mildly Reduced Ejection Fraction: Impacting Health Outcomes with Nonsteroidal MRAs: Explore how the use of nonsteroidal mineralocorticoid receptor antagonists (MRAs) can improve outcomes in patients with heart failure, particularly those with preserved or mildly reduced ejection fraction.
6. Hypertrophic Cardiomyopathy Masterclass: Rapid Fire Case Consults: In this hands-on masterclass, we will work through real-life hypertrophic cardiomyopathy (HCM) cases, providing expert insights and interactive discussions on the latest diagnostic and therapeutic approaches.
These sessions are more than just symposia— they offer an opportunity to engage with leading cardiology experts, participate in thought-provoking discussions, and gain insights that can immediately enhance clinical practice. Don’t miss this chance to take your cardiology practice to the next level. Register today and secure your spot for these educational opportunities!
Additionally, be sure to join us for a highly anticipated oral presentation on “Echocardiography in Hypertrophic Cardiomyopathy: Virtual CME Advances Physician Knowledge and Confidence,” November 18th from 9:40 am – 9:45 am, during the Imaging and Technologies in Heart Failure digital poster session.
For more information on Cardiology Education, contact David Anderson.
We look forward to seeing you at AHA 2024 in Chicago, IL!
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Medscape Education and M4RD: Together Caring for Rare Disease
We are excited to finally share our news-style video ' ', developed in partnership with Medics 4 Rare Diseases (M4RD) and produced by Genetic Alliance UK and ITN Business.For more information on...
The Need for and Impact of Rare Disease Education
Physicians are often told that when they hear hoofbeats, think horses, not zebras — to look for the most common cause of a patient’s symptoms first. While this advice may...
Medscape Education: Rare Diseases Fibrodysplasia Ossificans Progressiva
Rare Disease Day is on February 28.Listen to Nicky explain her daughter's journey with fibrodysplasia ossificans progressiva.Many patients face long waits for accurate diagnosis and treatment, making it critically important...
Medscape Education: Rare Diseases
It's only a few days until #RareDiseaseDay2023 on 28th February. We're taking a patient centered approach, this means understanding their journey so we can better understand how we can help to...
Together Caring for Rare Disease
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
Medscape Education Wins Best Practice Award for Learner Outcomes at NAMEC
This year's winners have been announced for the National Association of Medical Education Companies (NAMEC) awards. These awards recognize best practices-ideas or processes that can be implemented by NAMEC members to...
Medscape Education and Medics4RareDisease Uncover the Education Gaps in Their Compelling Rare Disease Day Campaign
Medscape Education and Medics4RareDisease are partnering on a Rare Disease Day awareness campaign. The campaign will form part of a series of short programs produced by ITN in collaboration with Genetic Alliance...
What Does Net Promoter Score Offer in the Evaluation of Continuing Medical Education?
Net promoter Score (NPS) has been used in many fields, such as software, clinical care, and websites, as a measure of customer satisfaction since 2003. With a single question, NPS...
DIGITAL HEALTH IN PRACTICE AND OVERCOMING DIGITAL FATIGUE
During this year’s Reuters event, Pharma 2022, WebMD CMO, Dr John Whyte discussed the ways in which digital health is growing, and the importance of educating clinicians in the right...
ESMO’s New Focus on Cancer Prevention
During ESMO 2022 in Paris, John Whyte, chief medical officer at WebMD was joined by Fabrice André, MD, PhD, Chair of the scientific committee at the European Society for Medical Oncology (ESMO),...